Miranda Patterson

1.1k total citations
14 papers, 818 citations indexed

About

Miranda Patterson is a scholar working on Oncology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Miranda Patterson has authored 14 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Molecular Biology and 5 papers in Infectious Diseases. Recurrent topics in Miranda Patterson's work include Antifungal resistance and susceptibility (5 papers), PARP inhibition in cancer therapy (5 papers) and DNA Repair Mechanisms (4 papers). Miranda Patterson is often cited by papers focused on Antifungal resistance and susceptibility (5 papers), PARP inhibition in cancer therapy (5 papers) and DNA Repair Mechanisms (4 papers). Miranda Patterson collaborates with scholars based in United Kingdom, United States and Germany. Miranda Patterson's co-authors include Janet Quinn, Deborah A. Smith, Alessandra da Silva Dantas, Nicola J. Curtin, Ashleigh Herriott, David C. Smith, Lauren A. Byers, Lida A. Mina, Zev A. Wainberg and Joshua W. Henshaw and has published in prestigious journals such as Molecular and Cellular Biology, British Journal of Cancer and Molecular Biology of the Cell.

In The Last Decade

Miranda Patterson

12 papers receiving 807 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Miranda Patterson United Kingdom	11	427	426	233	174	98	14	818
Ana B. Herrero Spain	21	229 0.5×	729 1.7×	98 0.4×	133 0.8×	60 0.6×	42	1.1k
Tokuichi Kawaguchi Japan	15	132 0.3×	311 0.7×	86 0.4×	173 1.0×	98 1.0×	22	799
Yueyong Liu China	17	209 0.5×	600 1.4×	130 0.6×	88 0.5×	60 0.6×	27	913
Zhaojing Zhong United States	9	146 0.3×	316 0.7×	267 1.1×	333 1.9×	115 1.2×	12	824
Sarah Maguire United Kingdom	11	128 0.3×	607 1.4×	151 0.6×	120 0.7×	49 0.5×	17	874
Sergey Tcherniuk France	14	130 0.3×	390 0.9×	114 0.5×	184 1.1×	102 1.0×	21	696
Bianhong Zhang China	15	155 0.4×	435 1.0×	65 0.3×	145 0.8×	283 2.9×	39	843
Saumitra Das India	22	246 0.6×	1.0k 2.4×	181 0.8×	217 1.2×	161 1.6×	59	1.6k
Peter O. Simon United States	13	277 0.6×	388 0.9×	104 0.4×	71 0.4×	321 3.3×	20	1.1k

Countries citing papers authored by Miranda Patterson

Since Specialization

Citations

This map shows the geographic impact of Miranda Patterson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miranda Patterson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miranda Patterson more than expected).

Fields of papers citing papers by Miranda Patterson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miranda Patterson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miranda Patterson. The network helps show where Miranda Patterson may publish in the future.

Co-authorship network of co-authors of Miranda Patterson

This figure shows the co-authorship network connecting the top 25 collaborators of Miranda Patterson. A scholar is included among the top collaborators of Miranda Patterson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miranda Patterson. Miranda Patterson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Bono, Johann S. de, Ramesh K. Ramanathan, Lida A. Mina, et al.. (2017). Phase I, Dose-Escalation, Two-Part Trial of the PARP Inhibitor Talazoparib in Patients with Advanced Germline BRCA1/2 Mutations and Selected Sporadic Cancers. Cancer Discovery. 7(6). 620–629. 314 indexed citations

Hogarth, Linda, Miranda Patterson, David Jamieson, et al.. (2017). P2.01-070 Circulating Biomarkers of Frailty Are Associated with a Poor Prognosis in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC). Journal of Thoracic Oncology. 12(1). S829–S830.

Patterson, Miranda, Sadri Znaidi, Alessandra da Silva Dantas, et al.. (2016). Mechanisms Underlying the Delayed Activation of the Cap1 Transcription Factor in Candida albicans following Combinatorial Oxidative and Cationic Stress Important for Phagocytic Potency. mBio. 7(2). e00331–e00331. 32 indexed citations

Middleton, Fiona K., Miranda Patterson, Sarah Fordham, et al.. (2015). Common cancer-associated imbalances in the DNA damage response confer sensitivity to single agent ATR inhibition. Oncotarget. 6(32). 32396–32409. 47 indexed citations

Herriott, Ashleigh, Susan J. Tudhope, Miranda Patterson, et al.. (2015). PARP1 expression, activity andex vivosensitivity to the PARP inhibitor, talazoparib (BMN 673), in chronic lymphocytic leukaemia. Oncotarget. 6(41). 43978–43991. 29 indexed citations

Murray, J. C., Huw D. Thomas, P. Berry, et al.. (2014). Tumour cell retention of rucaparib, sustained PARP inhibition and efficacy of weekly as well as daily schedules. British Journal of Cancer. 110(8). 1977–1984. 33 indexed citations

Patterson, Miranda, Robert Sharrock, Angelika Kaufmann, et al.. (2014). Assessing the function of homologous recombination DNA repair in malignant pleural effusion (MPE) samples. British Journal of Cancer. 111(1). 94–100. 19 indexed citations

Jacobsen, Mette D., Zhikang Yin, Miranda Patterson, et al.. (2014). Mechanisms Underlying the Exquisite Sensitivity of Candida albicans to Combinatorial Cationic and Oxidative Stress That Enhances the Potent Fungicidal Activity of Phagocytes. mBio. 5(4). e01334–14. 73 indexed citations

Patterson, Miranda, Christopher McKenzie, Deborah A. Smith, et al.. (2013). Ybp1 and Gpx3 Signaling in Candida albicans Govern Hydrogen Peroxide-Induced Oxidation of the Cap1 Transcription Factor and Macrophage Escape. Antioxidants and Redox Signaling. 19(18). 2244–2260. 63 indexed citations

10.

Henshaw, Joshua W., Huiyu Zhou, Ashleigh Herriott, et al.. (2013). Abstract A220: Inhibition of PBMC PARP activity with the novel PARP 1/2 inhibitor BMN 673 in patients with advanced solid tumors.. Molecular Cancer Therapeutics. 12(11_Supplement). A220–A220. 1 indexed citations

11.

Dantas, Alessandra da Silva, Miranda Patterson, Deborah A. Smith, et al.. (2010). Thioredoxin Regulates Multiple Hydrogen Peroxide-Induced Signaling Pathways in Candida albicans. Molecular and Cellular Biology. 30(19). 4550–4563. 99 indexed citations

12.

Smith, Deborah A., et al.. (2007). A Single MAPKKK Regulates the Hog1 MAPK Pathway in the Pathogenic FungusCandida albicans. Molecular Biology of the Cell. 18(11). 4603–4614. 92 indexed citations

13.

Izak, G., S. M. Lewis, Miranda Patterson, & F Turpin. (1967). Reticulocyte Function in PNH: in vitro Study of Haemoglobin Synthesis. Scandinavian Journal of Haematology. 4(5). 351–360. 2 indexed citations

14.

Fairley, G. Hamilton, Miranda Patterson, & Ronald Bodley Scott. (1966). Chemotherapy of Hodgkin's Disease with Cyclophosphamide, Vinblastine, and Procarbazine. BMJ. 2(5505). 75–78. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact